Labelled compounds as radiopharmaceuticals for radiosynoviorthesis by Melichar, F., Kropacek, M., Srank, J., Beran, M., Mirzajevova, M., Zimova, J., Eigner-Henke, K., Forsterova, M.

Get full text

Spectroscopic characterization of Eu(III) complexes with new monophosphorus acid derivatives of H(4)dota by Táborský, Petr, Svobodová, Ivona, Hnatejko, Zbigniew, Lubal, Pemysl, Lis, Stefan, Försterová, Michaela, Hermann, Petr, Lukes, Ivan, Havel, Josef

Get full text

Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma by Lokvenc, M., Kalinova, Marketa, Forsterova, K., Klener, P., Trneny, M., Fronkova, E., Kodet, R.

Get full text

Sequencing‐based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy by Karolová, J, Kazantsev, D, Svatoň, M, Tušková, L, sterová, K, Maláriková, D, Benešová, K, Heizer, T, Dolníková, A, Klánová, M, Winkovska, L, Svobodová, K, Hojný, J, Krkavcová, E, Froňková, E, Zemanová, Z, Trněný, M, Klener, P

Get full text

The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab by Benesova, K, Forsterova, K, Votavova, H, Campr, V, Stritesky, J, Velenska, Z, Prochazka, B, Pytlik, R, Trneny, M

Get full text

The Anticancer Drug Ellipticine Forms Covalent DNA Adducts, Mediated by Human Cytochromes P450, through Metabolism to 13-Hydroxyellipticine and Ellipticine N 2-Oxide by Stiborová, Marie, Sejbal, Jan, Bořek-Dohalská, Lucie, Aimová, Dagmar, Poljaková, Jitka, Forsterová, Kristina, Rupertová, Martina, Wiesner, Jiří, Hudeček, Jiří, Wiessler, Manfred, Frei, Eva

Get full text

R‐CHOP/R‐HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS by Klener, P., Fronkova, E., Belada, D., Forsterova, K., Pytlik, R., Kalinova, M., Simkovic, M., Salek, D., Mocikova, H., Prochazka, V., Blahovcová, P., Janikova, A., Markova, J., Obr, A., Berkova, A., Vaskova, M., Mejstrikova, E., Campr, V., Kubinyi, J., Jaksa, R., Kodet, R., Michalova, K., Trka, J., Trneny, M.

Get full text

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 by Obr, A, Maláriková, D, Kriegová, E, Zemanová, Z, Urbánková, H, Hrušková, A, Kovaříková, P, Petráčková, A, Vatolíková, M, Maňáková, J, Benešová, K, Forsterová, K, Cigánková, P, Papajík, T, Trněný, M, Klener, P

Get full text

TYPE OF ATM ABERRATION HAS A DIFFERENT IMPACT ON SURVIVAL PARAMETERS IN MANTLE CELL LYMPHOMA by Obr, A., Maláriková, D., Kriegová, E., Zemanová, Z., Urbánková, H., Hrušková, A., Kovaříková, P., Petráčková, A., Vatolíková, M., Maňáková, J., Benešová, K., Forsterová, K., Cigánková, P., Papajík, T., Trněný, M., Klener, P.

Get full text

ESTABLISHED CELL LINES AND PATIENT‐DERIVED XENOGRAFTS REPRESENT EQUALLY RELEVANT MODELS OF AGGRESSIVE LYMPHOMAS by Klener, P., Klánová, M., Molinský, J., Svatoň, M., Berková, A., Zemanová, Z., Jakša, R., Špaček, M., Březinová, J., Tichá, I., Jančušková, T., Hardekopf, D.W., Forsterová, K., Froňková, E., Kotrová, M., Kubričanová‐Žaliová, M., Maswabi, B.C., Průková, D., Vočková, P., Tušková, D., Michalová, K., Trka, J., Trněný, M., Klener, P.

Get full text